Respiratory syncytial virus causes lower respiratory tract illnesses such as bronchiolitis or pneumonia. To stop its expansion, Pfizer developed the first-to-market vaccine aimed at pregnant women and women over 60 years of age. This virus accounts for more than 60% of acute respiratory infections in infants and young children worldwide. The vaccine, through immunization of the mother, gives the baby antibodies during the first six months of life, when the baby is most vulnerable. Adults can also suffer severe illness from syncytial virus, especially those who are over 60 years of age or have chronic heart disease, COPD, asthma, or are immunocompromised. The vaccine is now available in Spain and should be used in accordance with official recommendations. It is given as a single dose to pregnant women between 24 and 36 weeks’ gestation. As for the indications for active immunization of persons over 60 years of age for the prevention of RSV disease, they are not included in the reimbursement of the General Pharmacy Directorate.
Article for subscribers only
Unlimited access to better journalism
See comments
Mark Piasecki/WireImage Fin des nuis with Spanish justice for the singer, individual footballer Gerard Pique…
Eight Hezbollah militants killed in Israeli strike in SyriaAt least eight alleged members of the…
In Spain, 40,203 new cases of colorectal cancer were diagnosed in 2023 - according to…
Primitive result 03, 10, 14, 16, 28 and 35The Primitiva draw on Monday 20 May…
Ghost of Tsushima: Director's Cut was the second best PlayStation release on PC. The open-world…
A video circulating on social media allows us to verify what he said. Kylian Mbappe…